Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study

6 Feb 2023

Abstract excerpt

As a specific predictor of ovarian reserve, serum anti-Müllerian hormone (AMH) has become an area of intense research interest in the field of assisted reproductive technology. We assessed the relationship between AMH levels and pregnancy outcomes in Chinese patients and investigate the influencing factors of cumulative live birth in patients with high AMH levels. A total of 1379 patients starting their IVF/ICSI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Ovarian function and disorders
Share to Reproductive Biology and Fertility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36746984
DOI: 10.1038/s41598-023-28724-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort studyPMID 36746984Read ↗

High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndromeSemantic proximity Read ↗

Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary SyndromeSemantic proximity Read ↗

Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer.Semantic proximity Read ↗

IVF Outcomes of Patients in women with Isolated Hypogonadotropic Hypogonadism: a retrospective study in ChinaSemantic proximity Read ↗

The role of Anti-Mullerian hormone in predicting fertilization and pregnancy rates following in vitro fertilization-embryo transfer (IVF-ET) and intracytoplasmic sperm injection (ICSI) cycles at a public fertility centre in NigeriaSemantic proximity Read ↗

Using anti-Müllerian hormone to predict premature ovarian insufficiency: a retrospective cross-sectional studySemantic proximity Read ↗

Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Müllerian hormone.Semantic proximity Read ↗

Association of AMH and AMHR2 gene polymorphisms with ovarian response and pregnancy outcomes in Indian women.Semantic proximity Read ↗

AMH and AMHR2 polymorphisms and AMH serum level can predict assisted reproduction outcomes: a cross-sectional study.Semantic proximity Read ↗

Maternal Antimüllerian Hormone as a Predictor of Euploid Is Independently Associated With Cumulative Live Birth RatesSemantic proximity Read ↗

Anti-Mullerian Hormone:<i>Above and Beyond Conventional Ovarian Reserve Markers</i>Semantic proximity Read ↗

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients With Different SubgroupsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.